Back
MoonLake Immunotherapeutics Stock Predictions
Write This Down: Tuesday at 2 p.m. ET!
Don't Miss Our LIVE Trade
Sell
39
MLTX
MoonLake Immunotherapeutics
Last Price:
46.48
Seasonality Move:
18.28%
7 Day Trial
ALL ACCESS PASS
$
7
The Mysterious VC Firm Behind Nvidia's Secret Weapon
Details Here!MoonLake Immunotherapeutics Stock Forecast
- Over the next 52 weeks, MoonLake Immunotherapeutics has on average historically risen by 125.1% based on the past 4 years of stock performance.
- MoonLake Immunotherapeutics has risen higher in 1 of those 4 years over the subsequent 52-week period, corresponding to a historical accuracy of 25%
-
Is MoonLake Immunotherapeutics Stock Undervalued?
The current MoonLake Immunotherapeutics [MLTX] share price is $46.76. The Score for MLTX is 39, which is 22% below its historic median score of 50, and infers higher risk than normal. - MLTX is currently trading in the 30-40% percentile range relative to its historical Stock Score levels.
Will MoonLake Immunotherapeutics Stock Go Up Next Year?
- Over the next 52 weeks, MoonLake Immunotherapeutics has on average historically risen by 125.1% based on the past 4 years of stock performance.
MoonLake Immunotherapeutics Stock Rating
Sell
39
MoonLake Immunotherapeutics (MLTX)
is a Sell
Is MoonLake Immunotherapeutics overpriced?
- MoonLake Immunotherapeutics has risen higher in 1 of those 4 years over the subsequent 52-week period, corresponding to a historical accuracy of 25%
MoonLake Immunotherapeutics Stock Price History
Stock Information
Stock Info
Exchange:
NASDAQ
Country:
Switzerland
Industry:
Biotechnology
Sector:
Health Care
Type:
stock
Website:
moonlaketx.com
52-Week Data
52-Week High:
64.98
52-Week Low:
35.11
Prediction Charts
Market Cap:
2.94B
Price in USD:
46.76
Volume:
244.05K
Beta:
1.29
Technical Analysis
SMA50:
49.19
SMA100:
46.56
SMA200:
47.35
52-Wk Change:
-3.71%
Stock Predictions
-
Is MoonLake Immunotherapeutics stock public?
Yes, MoonLake Immunotherapeutics is a publicly traded company. -
What is the MoonLake Immunotherapeutics stock quote today?
The MoonLake Immunotherapeutics stock price is 46.76 USD today. -
How to buy MoonLake Immunotherapeutics stock online?
You can buy MoonLake Immunotherapeutics shares by opening an account at a top tier brokerage firm, such as TD Ameritrade or tastyworks.
14-Day Historical Data
| Date | Opening | Closing | Minimum | Maximum |
|---|---|---|---|---|
| Oct-14 | 49.04 | 48.90 | 50.24 | 48.36 |
| Oct-15 | 49.12 | 48.00 | 49.12 | 47.63 |
| Oct-16 | 48.36 | 49.12 | 49.27 | 47.90 |
| Oct-18 | 48.08 | 48.94 | 49.14 | 47.07 |
| Oct-21 | 48.87 | 49.02 | 49.73 | 48.29 |
| Oct-22 | 48.69 | 48.00 | 49.24 | 47.74 |
| Oct-23 | 48.00 | 46.59 | 48.00 | 46.25 |
| Oct-24 | 45.55 | 46.20 | 47.37 | 45.55 |
| Oct-25 | 46.58 | 46.70 | 47.22 | 46.07 |
| Oct-28 | 47.21 | 48.09 | 48.09 | 46.77 |
| Oct-29 | 48.20 | 48.25 | 48.47 | 47.52 |
| Oct-30 | 48.02 | 47.00 | 48.17 | 46.28 |
| Oct-31 | 47.02 | 46.38 | 47.03 | 45.24 |
| Nov-1 | 46.99 | 46.76 | 47.23 | 46.04 |
MoonLake Immunotherapeutics Earnings
MoonLake Immunotherapeutics Earnings Report: Per Share MoonLake Immunotherapeutics Earnings Q1 Q2 Q3 and Q4 last year and next year.
MoonLake Immunotherapeutics Forecast Revenue Growth
MoonLake Immunotherapeutics Stock Analysis: Historical quarterly revenues per share for MoonLake Immunotherapeutics and historical quarterly revenue growth:
- Analysts estimate an earnings decrease this quarter of $0.21 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.61 per share, and a decrease next year of $0.76 per share.
* MoonLake Immunotherapeutics stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.